KRAS Inhibitors Market
According to Intent Market Research, the KRAS Inhibitors Market is expected to grow from USD 1.4 billion in 2024-e at a CAGR of 15.3% to touch USD 3.3 billion by 2030. The KRAS Inhibitors Market is dominated by key players such as, Mirati Therapeutics Inc., Amgen Inc., Boehringer Ingelheim, Roche Holding AG, and Merck & Co., Inc.